These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 10188888)
1. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy. Nicolini A; Ferrari P; Sagripanti A; Carpi A Br J Cancer; 1999 Mar; 79(9-10):1443-7. PubMed ID: 10188888 [TBL] [Abstract][Full Text] [Related]
2. The role of tumour markers in improving the accuracy of conventional chest X-ray and liver echography in the post-operative detection of thoracic and liver metastases from breast cancer. Nicolini A; Carpi A; Ferrari P; Anselmi L; Spinelli C; Conte M; Miccoli P Br J Cancer; 2000 Dec; 83(11):1412-7. PubMed ID: 11076646 [TBL] [Abstract][Full Text] [Related]
3. Utility of a serum tumour marker panel in the post-operative follow-up of breast cancer patients with equivocal conventional radiological examinations. Nicolini A; Carpi A; Ferrari P; Pieri L Tumour Biol; 2003; 24(6):275-80. PubMed ID: 15004486 [TBL] [Abstract][Full Text] [Related]
4. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247 [TBL] [Abstract][Full Text] [Related]
5. Comparison of bone scintigraphy with serum tumor markers of CA 15-3 and carcinoembryonic antigen in patients with breast carcinoma. Gedik GK; Kiratli PO; Tascioglu B; Aras T Saudi Med J; 2006 Mar; 27(3):317-22. PubMed ID: 16532090 [TBL] [Abstract][Full Text] [Related]
6. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer. Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer. Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615 [TBL] [Abstract][Full Text] [Related]
9. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases]. Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740 [TBL] [Abstract][Full Text] [Related]
10. CA 15-3 and bone scintigraphy in the follow-up of breast cancer. Younsi N; Montravers F; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN Int J Biol Markers; 1997; 12(4):154-7. PubMed ID: 9582604 [TBL] [Abstract][Full Text] [Related]
11. Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma. Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Skopljak A Bosn J Basic Med Sci; 2006 Feb; 6(1):75-7. PubMed ID: 16533185 [TBL] [Abstract][Full Text] [Related]
12. A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients. Nicolini A; Carpi A; Di Marco G; Giuliani L; Giordani R; Palla S Cancer; 1989 May; 63(10):2037-46. PubMed ID: 2702573 [TBL] [Abstract][Full Text] [Related]
13. Can tumour marker assays be a guide in the prescription of bone scan for breast and lung cancers? Buffaz PD; Gauchez AS; Caravel JP; Vuillez JP; Cura C; Agnius-Delord C; Fagret D Eur J Nucl Med; 1999 Jan; 26(1):8-11. PubMed ID: 9933655 [TBL] [Abstract][Full Text] [Related]
14. Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients. Pectasides D; Pavlidis N; Gogou L; Antoniou F; Nicolaides C; Tsikalakis D Am J Clin Oncol; 1996 Oct; 19(5):459-64. PubMed ID: 8823487 [TBL] [Abstract][Full Text] [Related]
15. A novel method for monitoring high-risk breast cancer with tumor markers: CA 15.3 compared to CEA and TPA. Sölétormos G; Nielsen D; Schiøler V; Skovsgaard T; Winkel P; Mouridsen HT; Dombernowsky P Ann Oncol; 1993 Dec; 4(10):861-9. PubMed ID: 8117606 [TBL] [Abstract][Full Text] [Related]
16. [Procollagen-I, collagen telopeptide I, CEA, CA 15-3 as compared to bone scintigraphy in patients with breast cancer]. Zissimopoulos A; Petrakis G; Stellos K; Baziotis N Hell J Nucl Med; 2006; 9(1):60-4. PubMed ID: 16617400 [TBL] [Abstract][Full Text] [Related]
17. The Role of TPS and TPA in the Diagnostics of Distant Metastases. Kucera R; Topolcan O; Fiala O; Kinkorova J; Treska V; Zedníková I; Slouka D; Simanek V; Safanda M; Babuska V Anticancer Res; 2016 Feb; 36(2):773-7. PubMed ID: 26851038 [TBL] [Abstract][Full Text] [Related]
18. Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer. Findeisen R; Albrecht S; Richter B; Deutschmann K; Distler W Clin Chem Lab Med; 1998 Nov; 36(11):841-6. PubMed ID: 9877089 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of bone and liver metastases in breast cancer comparing tumor markers and imaging techniques. Zanco P; Rota G; Sportiello V; Borsato N; Ferlin G Int J Biol Markers; 1989; 4(2):103-5. PubMed ID: 2768888 [TBL] [Abstract][Full Text] [Related]
20. Relationship between bone scintigraphy and tumor markers in patients with breast cancer. Yildiz M; Oral B; Bozkurt M; Cobaner A Ann Nucl Med; 2004 Sep; 18(6):501-5. PubMed ID: 15515750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]